Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.
Standard
Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. / Oechsle, Karin; Lange-Brock, Victoria; Krüll, Andreas; Bokemeyer, Carsten; De Wit, Maike.
in: J CANCER RES CLIN, Jahrgang 136, Nr. 11, 11, 2010, S. 1729-1735.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.
AU - Oechsle, Karin
AU - Lange-Brock, Victoria
AU - Krüll, Andreas
AU - Bokemeyer, Carsten
AU - De Wit, Maike
PY - 2010
Y1 - 2010
N2 - Leptomeningeal metastases (LM) are associated with very poor prognosis and data on outcome are limited. We evaluated prognostic factors and treatment options in patients (pts) with LM of different malignancies in a single center experience.
AB - Leptomeningeal metastases (LM) are associated with very poor prognosis and data on outcome are limited. We evaluated prognostic factors and treatment options in patients (pts) with LM of different malignancies in a single center experience.
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Adolescent
KW - Prognosis
KW - Survival Analysis
KW - Combined Modality Therapy
KW - Proportional Hazards Models
KW - Retrospective Studies
KW - Neoplasms drug therapy
KW - Hematologic Neoplasms drug therapy
KW - Lung Neoplasms drug therapy
KW - Melanoma drug therapy
KW - Meningeal Carcinomatosis drug therapy
KW - Neoplasm Metastasis drug therapy
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Adolescent
KW - Prognosis
KW - Survival Analysis
KW - Combined Modality Therapy
KW - Proportional Hazards Models
KW - Retrospective Studies
KW - Neoplasms drug therapy
KW - Hematologic Neoplasms drug therapy
KW - Lung Neoplasms drug therapy
KW - Melanoma drug therapy
KW - Meningeal Carcinomatosis drug therapy
KW - Neoplasm Metastasis drug therapy
M3 - SCORING: Zeitschriftenaufsatz
VL - 136
SP - 1729
EP - 1735
JO - J CANCER RES CLIN
JF - J CANCER RES CLIN
SN - 0171-5216
IS - 11
M1 - 11
ER -